Produ????o heter??loga de polihidroxialcanoato sintase (PhaC), biocatalisador da s??ntese de Poli (??cido l??tico) (PLA) em Komagataella phaffii

• Autor(a) principal: Costa, Tha??s Duarte
• Data de Publicação: 2018
• Tipo de documento: Dissertação
• Idioma: por
• Título da fonte: Biblioteca Digital de Teses e Dissertações da UCB
• Texto Completo: https://bdtd.ucb.br:8443/jspui/handle/tede/2406
• topic: Biopl??stico; Biocatalisador; Komagataella phaffii; Poli (??cido l??tico) (PLA); BioplasticPolihidroxialcanoato sintase (phaC); Polyhydroxyalkanoate synthase (phaC); Poly lactic acid (PLA); Biocatalyst; CNPQ::CIENCIAS BIOLOGICAS::BIOQUIMICA

Polyethylene terephthalate (PET) based plastics are serious environmental problem due to long decomposition periods and petroleum-dependent origin. Therefore, bioplastics are a promising alternative as their synthesized by the polimerization of renewable raw materials, yeilding biodegradable and environmental-friendly products. One of the most relevant polymers in this scenario is the poly lactic acid (PLA) formed from lactic acid monomers. The main characteristics of PLA are low toxicity to humans due to high biocompatibility, for example in biomedical materials, and biodegradability, which reduces their time in landfills due to the faster decomposition process. These properties provide wide applicability of this polymer in various areas such as packaging, textiles and biomedical materials. Commonly, the chemical polymerization process of PLA can be carried out in two ways, (1) ring opening for further polymerization or (2) condensation of the lactic acids. In both cases, the presence of metal catalysts such as zinc, aluminum and magnesium is required. These, in addition to being toxic, hinder the use of the polymer, for instance, in the biomedical area, for generating metallic waste. An alternative to such catalysts is the use of biocatalysts. Polyhydroxyalkanoate synthase (phaC) has been previously used for the polymerization of lactic acid produced in recombinant strains of Escherichia coli. Thus, within the lactic acid production platform in recombinant Komagataella phaffi strains, the objective of this work is to produce the phaC enzyme with point mutations at the S325N and Q481I sites. These residue changes provide a greater specificity of the enzyme-substrate complex to act as a biocatalyst in the polymerization of lactic acid in Komagataella phaffi. In this study, three cloning strategies were performed between the phaCPs insert and pGAPZ??B vector. To date, there have been no transformants in any of the strategies. However, Strategy C has not yet been fully implemented, which also results in the possibility of cloning between phaCPs insert and pGAPZ??B expression vector with the correct sequence. It is expected that successful cloning, recombinant DNA sequencing and plasmid insertion into Komagataella phaffii genome can be performed to conclude this study.